|
|
Additional
Resources
|
|
Vitamin K, An Arthritis Preventative Home Remedy
Most all of us will have to deal with arthritis joint pain - joint inflammation and deterioration of cartilage - at some time. Arthritis occurs in the knees, elbow, fingers, and any where there Read more...
|
|
|
|
Arthritis
Do You Have Degenerative Arthritis?
With 10 million or more people with arthritis, the majority of them will have degenerative arthritis. This is called Osteoarthritis. Degenerative occurs when joints are overworked, rub against each other, experience excess friction, and slowly degenerate.Most joints rub against each other, but bone joints have a protective layer called cartilage. This cartilage has no blood vessels or nerves so it cannot receive nutrients directly. This cartilage serves as a cushion or pad between bones so that bones don't wear out and so you don't feel pain.Cartilage should not wear out if its surfaces remain lubricated with oils that you eat. But if you are not eating the right oils or the proper amount, then your cartilage can become dry. Under these conditions you will slowly deteriorate the cartilage, which will lead to degenerative arthritis.Once your cartilage becomes damage or grinded down, it is hard to regenerate it. Cartilage is not a living tissue and does not receive its nourishment directly from blood vessels. It is made up of mucin, albumin and sulfuric acid. It absorbs oils and nutrients by osmosis. Osmosis is the movement of oil from an area of high oil concentration passing through a membrane into an area of low oil concentration. So if the cartilage is deficient in oil and you don't eat the oil it needs to minimize cartilage-to-cartilage friction, then degenerative will occur over time.Eating oil that is high in vitamin D and iodine is what is necessary for good cartilage strength
and function. Oil such as cod liver oil is ideal as lubrication for cartilage function. Fish oil is another good oil to eat. When you eat cod liver oil, this oil passes through the joint lining into the joint cavity. Once in the cavity, this oil is absorbed into the cartilage through osmosis. Once the cartilage is properly lubricated, it has an elasticity and lubrication so that when it rubs against other cartilage little friction and cartilage degeneration occurs.There is another process that can affect the integrity of the cartilage. Calcium can deposit on the bone near the cartilage and breaking to the cartilage and wear it down. To prevent this condition, calcium must be kept in solution in the lymph liquid. This is done by maintain a balance diet.Degenerative is a process where the cartilage at the end of bones in joint structures slowly degrades. This degradation occurs from the lack of the right oil in the diet and through calcium build up in the bone joint. Joint degeneration starts to occur after the age of 20 and can continue if the right diet if not followed.Eating the right food to prevent degenerative is difficult to do if you have been brought up eating the wrong kinds of food. But as an adult you can now make a choice as to whether you will have Osteoarthritis when you get older by eating the foods..
We strive to provide only quality information, so
if
there is a specific topic related to arthritis
that you would
like us to cover, please contact us at any time.
And again, thank you to those contributing daily to
our Arthritis
Website, especially
regarding "degenerative arthritis".
Discounted
Arthritis Online Auction
If you can't find the
Arthritis information you are looking for please
try our Google
Search
Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: Biological: adalimumab (Humira)<br/><b>Sponsor</b>: Abbott<br/><b>Active, not recruiting</b> - verified February 2010
A Study on the Prevalence of the Anti-MCV Anti-body in an Irish Rheumatoid Arthritis (RA) Population and the Impact of Biomarker Status on the Management of Irish Patients With Early RA
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: Other: This is a non-drug study. No treatment is mandated by the protocol. Routine blood draws (as per normal clinical care) will be taken through the study.<br/><b>Sponsors</b>: Abbott; Clinical Trial End-Point (CTEP) Ltd; JSS Medical Research Inc.<br/><b>Not yet recruiting</b> - verified March 2010
Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthritis (RA)
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Abbott; Institute of Political Economical & Social Researches, Greece<br/><b>Active, not recruiting</b> - verified February 2010
Effectiveness of Adalimumab on Extraarticular Manifestation in Patients With Active Rheumatoid Arthritis
<b>Conditions</b>: Active Rheumatoid Arthritis; Osteoporoses<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Abbott; Centre of Biostatistics and Analyses, Faculty of Medicine, Masaryk University Brno, Czech Republic<br/><b>Recruiting</b> - verified February 2010
The Relation Between Dedicated Extremity MRI Synovitis and Structural Deterioration Radiographic in Patients With Rheumatoid Arthritis in Clinical Remission. Preliminary Study
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: Other: MRI<br/><b>Sponsor</b>: Centre Hospitalier Universitaire de Nice<br/><b>Not yet recruiting</b> - verified January 2010
Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Interventions</b>: Dietary Supplement: Oncoxin + Viusid; Dietary Supplement: Placebo<br/><b>Sponsor</b>: Catalysis SL<br/><b>Recruiting</b> - verified November 2009
Monitoring Epstein-Barr Virus (EBV) Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive Drugs
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: Biological: Venous blood sample<br/><b>Sponsor</b>: Assistance Publique Hopitaux De Marseille<br/><b>Recruiting</b> - verified October 2009
A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Interventions</b>: Drug: PF-04171327 10 mg; Other: Prednisone Placebo; Drug: PF-04171327 25 mg; Other: Prednisone Placebo; Drug: Prednisone 5 mg; Other: Placebo for PF-04171327; Other: Placebo; Other: Placebo for PF-04171327<br/><b>Sponsor</b>: Pfizer<br/><b>Recruiting</b> - verified March 2010
Targeting Synovitis in Early Rheumatoid Arthritis
<b>Conditions</b>: Rheumatoid Arthritis; Polyarthritis<br/><b>Interventions</b>: Other: Musculoskeletal Ultrasound; Other: 28 Joint Disease Activity Score<br/><b>Sponsors</b>: NHS Greater Glasgow and Clyde; University of Glasgow; Chief Scientist Office of the Scottish Government; Wyeth; Translational Medicine Research Collaboration<br/><b>Recruiting</b> - verified September 2009
Living Well With Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Interventions</b>: Behavioral: Self-Help Group; Other: Education (Control) Group<br/><b>Sponsors</b>: Brigham and Women's Hospital; Bristol-Myers Squibb<br/><b>Recruiting</b> - verified September 2009
A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Imperial College London; Merck<br/><b>Recruiting</b> - verified February 2010
Ultrasonography as a Biomarker in Early Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Imperial College London; Medical Research Council<br/><b>Recruiting</b> - verified February 2010
Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients
<b>Condition</b>: Active Rheumatoid Arthritis<br/><b>Intervention</b>: Drug: Etanercept<br/><b>Sponsor</b>: Wyeth<br/><b>Recruiting</b> - verified July 2009
A Study Comparing CRx-102 Plus Disease-Modifying Anti-Rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Interventions</b>: Other: CRx-102 plus DMARD therapy; Other: Placebo plus DMARD therapy<br/><b>Sponsor</b>: CombinatoRx<br/><b>Completed</b> - verified September 2008
Effects of Tranilast on Pharmacokinetics of Methotrexate (MTX) in Patients With Rheumatoid Arthritis (RA)
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Interventions</b>: Drug: Tranilast; Drug: Placebo comparator<br/><b>Sponsors</b>: Imperial College London; Nuon Therapeutics, Inc.<br/><b>Withdrawn</b> - verified July 2009
RESTART C0168Z05 Rheumatoid Arthritis Study
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: Biological: Infliximab<br/><b>Sponsors</b>: Centocor Ortho Biotech Services, L.L.C.; Schering-Plough<br/><b>Active, not recruiting</b> - verified January 2010
Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?
<b>Conditions</b>: Rheumatoid Arthritis; Arthritis; Joint Diseases<br/><b>Intervention</b>: Drug: Adalimumab (Humira)<br/><b>Sponsors</b>: Hvidovre University Hospital; Abbott<br/><b>Completed</b> - verified June 2008
Rosuvastatin in Rheumatoid Arthritis (RORA)
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Interventions</b>: Drug: rosuvastatin; Drug: placebo<br/><b>Sponsor</b>: University of Dundee<br/><b>Completed</b> - verified May 2008
Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Interventions</b>: Drug: Certolizumab pegol; Other: Placebo<br/><b>Sponsor</b>: UCB, Inc.<br/><b>Recruiting</b> - verified February 2010
Study Evaluating Single Doses of SBI-087 in Subjects With Rheumatoid Arthritis
<b>Condition</b>: Rheumatoid Arthritis<br/><b>Intervention</b>: Drug: SBI-087<br/><b>Sponsors</b>: Wyeth; Trubion Pharmaceuticals<br/><b>Active, not recruiting</b> - verified July 2009
|
|
